News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,070 Results
Type
Article (28)
Press Release (3042)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (1)
Alliances (42)
Alzheimer's disease (28)
Approvals (106)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (6)
Cancer (55)
Career advice (1)
Clinical research (626)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (67)
Diabetes (1)
Diagnostics (21)
Drug discovery (1)
Drug pricing (1)
Earnings (1437)
Events (326)
FDA (130)
Frontotemporal dementia (1)
Funding (3)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (9)
Guidances (10)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (25)
Lymphoma (6)
Manufacturing (1)
MASH (4)
Medical device (56)
Medtech (56)
Mergers & acquisitions (23)
Metabolic disorders (6)
Multiple sclerosis (2)
NASH (1)
Neuroscience (34)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Parkinson's disease (1)
Peanut (1)
People (8)
Phase I (94)
Phase II (190)
Phase III (370)
Pipeline (54)
Policy (1)
Postmarket research (27)
Preclinical (12)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (5)
Regulatory (144)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (1)
Schizophrenia (2)
Startups (3)
Vaccines (5)
Date
Today (4)
Last 7 days (15)
Last 30 days (38)
Last 365 days (417)
2025 (153)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (333)
Australia (13)
California (52)
Canada (16)
China (10)
Connecticut (3)
Delaware (15)
Europe (609)
Florida (8)
Georgia (2)
Illinois (6)
Indiana (17)
Japan (8)
Maryland (12)
Massachusetts (40)
Minnesota (3)
New Jersey (47)
New York (27)
North Carolina (9)
Northern California (34)
Ohio (2)
Pennsylvania (22)
South America (5)
Southern California (14)
Texas (8)
United States (277)
Utah (6)
Washington State (3)
3,070 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amgen’s TEPEZZA®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted Treatment Specifically for Adults With Moderate-to-severe Thyroid Eye Disease (TED) in the United Kingdom
May 8, 2025
·
8 min read
Press Releases
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
March 31, 2025
·
7 min read
Press Releases
80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
April 29, 2025
·
5 min read
Press Releases
XORTX Provides Update on FDA Type B Meeting Request
April 30, 2025
·
8 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter
April 24, 2025
·
20 min read
Press Releases
4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
May 9, 2025
·
10 min read
Press Releases
Guerbet: Q1 2025 revenue
April 25, 2025
·
7 min read
Press Releases
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
·
12 min read
Press Releases
CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings
April 30, 2025
·
10 min read
Press Releases
Emergent BioSolutions Reports First Quarter 2025 Financial Results
May 8, 2025
·
31 min read
1 of 307
Next
